Aspirin restores normal baroreflex function in hypercholesterolemic rats by its antioxidative action

European Journal of Pharmacology

Volumn 556, Issue 1-3, 2007, Pages 136-143

  Tauseef, Mohammad ^a   Sharma, Krishna K ^b   Fahim, Mohammad ^a  

^a UNIVERSITY OF DELHI   (India)

^b UNIVERSITY COLLEGE OF MEDICAL SCIENCES   (India)

Author keywords

Antioxidant; Aspirin; Baroreflex; Blood pressure; Free radical; Hypercholesterolemia; Lipid peroxidation; Reduced glutathione

Indexed keywords

ACETYLSALICYLIC ACID; ANTIOXIDANT; FREE RADICAL; GLUTATHIONE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROGENESIS; ATTENUATION; CONTROLLED STUDY; DIETARY INTAKE; DRUG EFFICACY; HEART RATE; HEMODYNAMICS; HYPERCHOLESTEROLEMIA; HYPERTENSION; LIPID BLOOD LEVEL; LIPID PEROXIDATION; MALE; MULTIPLE CYCLE TREATMENT; NONHUMAN; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIOXIDANTS; ASPIRIN; BAROREFLEX; BLOOD PRESSURE; CHOLESTEROL; CHOLESTEROL, DIETARY; HEART RATE; HYPERCHOLESTEROLEMIA; LIPID PEROXIDATION; LIPIDS; MALE; RATS; RATS, WISTAR;

EID: 33846065151     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.11.029     Document Type: Article

References (41)

1. Angell-James J.E. Arterial baroreceptor activity in rabbits with experimental atherosclerosis. Circ. Res. 34 (1974) 27-39
2. Aruoma O.I., and Halliwel B. The iron binding and iron hydroxyl scavenging action of anti-inflammatory drugs. Xenobiotics 18 (1988) 459-470
3. Ashraf Z.A., Hussain M.E., and Fahim M. Antiatherosclerotic effects of dietary supplementation of garlic and turmeric: restoration of endothelial function in rats. Life Sci. 77 (2005) 837-857
4. Chapleau M.W., Hajduczok G., and Abboud F.M. Peripheral and central mechanism of baroreflex resetting. Clin. Exp. Pharmacol. Physiol. 15 (1989) 31-43 (suppl)
5. Chapleau M.W., Hajduczok G., and Abboud F.M. Paracrine role of prostanoids in activation of arterial baroreceptor: an overview. Clin. Exp. Hypertens., Part A Theory Pract. 13 (1991) 817-824
6. Chen M., Masaki T., and Sawamura T. Lox-1, the receptor for oxidized low-density lipoprotein identified from endothelial cells: implications in endothelial dysfunction and atherosclerosis. Pharmacol. Ther. 95 (2000) 89-100
7. Costanzo A., Moretti F., Burgio V.L., Bravi C., Guido F., Levero M., and Puri P.L. Endothelial activation by angiotensin II through NF-kappa B and p38 pathways: involvement of NF-kappa B-inducible kinase (NIK), free radicals, and selective inhibition by aspirin. J. Cell. Physiol. 195 (2003) 402-410
8. Cox R.H., Ragshaw R.J., and Detweiler D.K. Alterations in carotid sinus reflex control of arterial hemodynamics associated with experimental hyperlipidemia in the racing greyhound. Circ. Res. 46 (1980) 237-244
9. Cyrus T., Sung S., Zhao L., Funk C.D., Tang S., and Pratico D. Effect of low dose aspirin on vascular inflammation, plaque stability and atherogenesis in low-density lipoprotein receptor-deficient mice. Circulation 106 (2002) 1282-1287
10. Dhalla N.S., Temshah R.M., and Netticadan T. Role of oxidative stress in cardiovascular diseases. J. Hypertens. 18 (2000) 655-673
11. El-Midaoui A., Wu R., and de Champlain J. Prevention of hypertension, hyperglycemia and vascular oxidative stress by aspirin treatment in chronically glucose-fed rats. J. Hypertens. 20 (2002) 1407-1412
12. Fahim M. Cardiovascular sensory receptors and their regulatory mechanisms. Indian J. Physiol. Pharmacol. 47 (2003) 124-146
13. Fields M., Lewis C.G., and Bureau I. Aspirin reduces blood cholesterol in copper deficient rats: a potential antioxidant agent. Metabolism 50 (2001) 558-561
14. Girouard H., Denault C., Chulak C., and de Champlain J.D. Treatment by N-acetylcysteine and melatonin increases cardiac baroreflex and improves antioxidant reserve. Am. J. Hypertens. 17 (2004) 947-954
15. Gokkusu C., and Mostafazadeh T. Changes of oxidative stress in various tissues by long-term administration of vitamin E in hypercholesterolemic rats. Clin. Chim. Acta 328 (2003) 155-161
16. Grosser N., and Schröder H. Aspirin protects endothelial cells from oxidant damage via the nitric oxide-cGMP pathway. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 1345-1351
17. Hosomi H., Katsuda S., and Watanabe Y. Effect of atherosclerosis on the responsiveness of the rapidly acting arterial pressure control system in WHHL rabbits. Cardiovasc. Res. 22 (1986) 679-685
18. Hussain S., Andrews N.P., Mulcahy D., Panza J.A., and Quyyumi A.A. Aspirin improves endothelial dysfunction in atherosclerosis. Circulation 97 (1998) 716-720
19. Jollow D.J., Mitchell J.R., Zampaglione N., and Gillette J.R. Bromobenzene induced liver necrosis: protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite. Pharmacology 11 (1974) 151
20. Kodama M., Yamasaki Y., Sakamoto K., Yoshioka R., Matsuhisa M., Kajimoto Y., Kosugi K., Ueda N., and Hori M. Antiplatelet drugs attenuate progression of carotid intima-mediated thickness in subjects with type 2 diabetes. Thromb. Res. 97 (2000) 239-245
21. Kouraklis G., Patapis P., Misiakos E., Glinavou A., Sioka C., and Karayiannakos P.E. Effect of acetylsalicylic acid on experimental atherogenesis induced in rabbits. Int. Angiol. 23 (2004) 139-143
22. Li Z., Mao H.Z., Abboud F.M., and Chapleau M.W. Oxygen-derived free radicals contribute to baroreceptor dysfunction in atherosclerotic rabbits. Circ. Res. 79 (1996) 802-811
23. Marfella R., Verrazzo G., Acampora R., La Marca C., Giunta R., Lucarelli C., Paolisso G., Ceriello A., and Giugliano D. Glutathione reverses systemic hemodynamic changes induced by acute hyperglycemia in healthy subjects. Am. J. Physiol. 268 (1995) E1167-E1173
24. Monobe H., Yamanari H., and Nakamura K. Effect of low-dose aspirin endothelial function in hypertensive patients. Clin. Cardiol. 24 (2001) 705-709
25. Oberle S., Polte T., Abate A., Podhaisky H.P., and Schroder H. Aspirin increases ferritin synthesis in endothelial cells: a novel antioxidant pathway. Circ. Res. 82 (1998) 1016-1020
26. Pandya N., Santani D., and Jain S. Antioxidant activity of ezetimibe in hypercholesterolemic rats. Indian J. Pharmacol. 38 (2006) 205-206
27. Podhaisky H.P., Abate A., Polte T., Oberle S., and Schröder H. Aspirin protects endothelial cells from oxidative stress: possible synergism with vitamin E. FEBS Lett. 417 (1997) 349-351
28. Prasad K., and Kalra J. Oxygen free radicals and hypercholesterolemic atherosclerosis. Am. Heart J. 125 (1993) 958-971
29. Rajagopalan S., Kurz S., Munzel T., Tarpey M., Freeman B.A., Griendling K.K., and Harrison D.G. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation: contribution to alterations of vasomotor tone. J. Clin. Invest. 97 (1996) 1916-1923
30. Ranke C., Hecker H., Creutzig A., and Alexander K. Dose-dependent effect of aspirin on carotid atherosclerosis. Circulation 87 (1993) 1873-1879
31. Ridker P.M., Cushman M., Stampfer M.J., Tracy R.P., and Hennekens C.H. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N. Engl. J. Med. 336 (1997) 973-979
32. Ross R. The pathogenesis of atherosclerosis-an update. N. Engl. J. Med. 314 (1986) 488-500
33. Saini S.K., Xu Y.J., Arneja A.S., Tappia P.S., and Dhalla N.S. Pharmacological basis of different targets for the treatment of atherosclerosis. J. Cell. Mol. Med. 9 (2004) 818-839
34. Sherman D.L., Keaney Jr. J.F., Biegelsen E.S., Dulfy S.J., Coffman J.D., and Vita J.A. Pharmacological concentrations of ascorbic acid are required for the beneficial effect on endothelial vasomotor function in hypertension. Hypertension 35 (2000) 936-941
35. Sobal G., Menzel J.E., and Sinzinger H. Influence of acetylsalicylic acid on oxidation of native and glycated low-density lipoprotein. Life Sci. 66 (2000) 1987-1998
36. Srisawat S., Phivthong-ngam L., Unchern S., Chantharaksri U., Govitrapong P., and Sanvarinda Y. Improvement of vascular function by chronic administration of a cyclo-oxygenase inhibitor in cholesterol-fed rabbits. Clin. Exp. Pharmacol. Physiol. 30 (2000) 405-412
37. Vlachakis N.D., Mendlowitz M., Guia D., and Gusman D. Diminished baroreceptor sensitivity in elderly hypertensives: possible role of atherosclerosis. Atherosclerosis 24 (1976) 243-249
38. Wollard A.C., Wolff S.P., and Bascal Z.A. Antioxidant characteristics of some potential anticataract agents: studies of aspirin, paracetamol and bendazac provide support for an oxidative component of cataract. Free Radic. Boil. Med. 9 (1990) 299-305
39. Wright J.R., Colby H.D., and Miles P.R. Cytosolic factors that affect microsomal lipid peroxidation in lung and liver. Arch. Biochem. Biophys. 206 (1981) 296-304
40. Wu R., Lamontagne D., and de Champlain J. Anti-oxidative properties of acetylsalicylic acid on vascular tissues from normotensive and spontaneously hypertensive rats. Circulation 105 (2002) 387-392
41. Yuan M., Konstantopoulos N., Lee J., Hansen L., Li Z.W., Karin M., et al. Reversal of obesity- and diet induced insulin resistance by salicylate or targeted disruption of IKKbeta. Science 293 (2001) 1673-1677